NCT02730325View on ClinicalTrials.gov

To Evaluate the Impact of SBI on C. Difficile in Hospitalized UC Patients

NATerminatedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 12, 2017

Study Completion Date

January 5, 2018

Conditions

Clostridium Difficile

Interventions

OTHER

Serum-derived bovine immunoglobulin/protein isolate (SBI)

OTHER

Placebo

Trial Locations (3)

33136

University of Miami, Miami

60611

Northwestern University, Chicago

60657

Rush University, Chicago

Sponsors

Collaborators (1)

Entera Health, Inc

All Listed Sponsors

collaborator

Entera Health, Inc

INDUSTRY

lead

Northwestern University

OTHER

NCT02730325 - To Evaluate the Impact of SBI on C. Difficile in Hospitalized UC Patients | Biotech Hunter | Biotech Hunter